CRIP1 and colorectal carcinoma: As FasL is predominantly expressed in activated T lymphocytes and Natural Killer (NK) cells that mediates cytotoxic apoptosis in the development of T/NK cells [33, 34], CRC derived CRIP1 might contribute to the regulation of FasL in the immune cells around the inflammatory environment of colorectal cancer.